The anti-acne drug Accutane has been linked to inflammatory bowel disease (IBD), a chronic gastrointestinal illness. Thousands of people who were injured have filed lawsuits.
Accutane Class Action Lawsuit Information
Hoffman-La Roche, the manufacturer of Accutane, has been hit with over 7,000 lawsuits accusing the company of downplaying risk information regarding inflammatory bowel disease (IBD). In 2009, they discontinued Accutane after juries awarded several multi-million dollar verdicts in favor of plaintiffs who developed IBD:
- $10.5 million awarded to a woman diagnosed with IBD at age 14 after taking Accutane for two years.
- $25 million awarded in 2010 to a man who needed five surgeries to treat IBD that occurred after he took Accutane for several years.
- $18 million awarded in 2012 to two women who were diagnosed with IBD after taking Accutane.
These lawsuits were not part of an Accutane class action — they were individual lawsuits filed by people who hired an attorney to represent their legal and financial interests. Many lawsuits were consolidated in a Multi-District Litigation (MDL) in Florida. Other mass torts were filed in New Jersey and Pennsylvania.